Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
- PMID: 27832612
- DOI: 10.1161/CIR.0000000000000455
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
Erratum in
-
Correction to: Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.Circulation. 2016 Dec 6;134(23):e652. doi: 10.1161/CIR.0000000000000474. Circulation. 2016. PMID: 27920080 No abstract available.
Keywords: AHA Scientific Statements; cardiomyopathy; dilated cardiomyopathy; heart failure.
Similar articles
-
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.Circulation. 2015 Dec 1;132(22):e273-80. doi: 10.1161/CIR.0000000000000239. Epub 2015 Nov 2. Circulation. 2015. PMID: 26621644 Review. No abstract available.
-
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.Circulation. 2016 Dec 6;134(23):e535-e578. doi: 10.1161/CIR.0000000000000450. Epub 2016 Oct 31. Circulation. 2016. PMID: 27799274 Review. No abstract available.
-
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation. 2013 Oct 15;128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5. Circulation. 2013. PMID: 23741057 No abstract available.
-
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.Circulation. 2014 Oct 28;130(18):1636-61. doi: 10.1161/CIR.0000000000000130. Epub 2014 Sep 22. Circulation. 2014. PMID: 25246013 No abstract available.
-
Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology.J Cardiovasc Med (Hagerstown). 2020 Dec;21(12):927-943. doi: 10.2459/JCM.0000000000001050. J Cardiovasc Med (Hagerstown). 2020. PMID: 32740436
Cited by
-
Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel.J Am Coll Cardiol. 2020 Sep 15;76(11):1345-1357. doi: 10.1016/j.jacc.2020.06.080. Epub 2020 Jul 22. J Am Coll Cardiol. 2020. PMID: 32710927 Free PMC article. Review.
-
Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach.Curr Cardiol Rep. 2020 Jul 9;22(9):85. doi: 10.1007/s11886-020-01343-9. Curr Cardiol Rep. 2020. PMID: 32648053 Free PMC article. Review.
-
Development and validation of a risk model for intracardiac thrombosis in patients with dilated cardiomyopathy: a retrospective study.Sci Rep. 2024 Jan 16;14(1):1431. doi: 10.1038/s41598-024-51745-w. Sci Rep. 2024. PMID: 38228722 Free PMC article.
-
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021.Heart Fail Rev. 2022 Nov;27(6):2033-2043. doi: 10.1007/s10741-022-10243-9. Epub 2022 Apr 22. Heart Fail Rev. 2022. PMID: 35449353 Free PMC article. Review.
-
Author's response to: letter to the editor.Heart Fail Rev. 2018 Sep;23(5):819. doi: 10.1007/s10741-018-9728-6. Heart Fail Rev. 2018. PMID: 30043131 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources